News
Tracking endogenous proteins based on RNA editing-mediated genetic code expansion Journal: Nature Chemical Biology Published: 2024-02-01 DOI: 10.1038/s41589-023-01533-w Affiliations: 3 Authors: 11 ...
The FDA has approved Isturisa (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has not been curative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback